Prevention of rheumatoid arthritis (RA) by intervening before the development of overt symptoms requires knowing which individuals are at risk of developing the disease. In this Review, Hunt and Emery consider several distinct at-risk cohorts, with a focus on those with systemic autoimmunity, and discuss the prospects for RA prevention in these cohorts drawing on lessons from disease prevention in other autoimmune conditions and early trials in RA.
